Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,559 | -31,896 | -110,776 | -85,670 | -59,675 |
| Depreciation Amortization | 3,570 | 1,791 | 8,201 | 6,368 | 4,538 |
| Accounts receivable | N/A | N/A | 31 | 31 | 31 |
| Accounts payable and accrued liabilities | -638 | -2,949 | 4,811 | 1,292 | 766 |
| Other Working Capital | -602 | -4,660 | 6,571 | 3,440 | -3,611 |
| Other Operating Activity | 37,591 | 10,367 | 17,857 | 20,288 | 16,707 |
| Operating Cash Flow | $-48,638 | $-27,347 | $-73,305 | $-54,251 | $-41,244 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 2,107 | 2,107 | 2,107 |
| PPE Investments | -575 | -391 | -2,280 | -2,130 | -1,637 |
| Investing Cash Flow | $-575 | $-391 | $-173 | $-23 | $470 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 20,000 | 39,377 | 39,377 | 39,377 |
| Debt Repayment | -1,247 | -603 | -33,756 | -33,168 | -32,591 |
| Common Stock Issued | 44,185 | 43,398 | 566 | 313 | 214 |
| Other Financing Activity | -610 | 0 | -1,680 | -1,680 | -1,394 |
| Financing Cash Flow | $62,328 | $62,795 | $4,507 | $4,842 | $5,606 |
| Beginning Cash Position | 80,801 | 80,801 | 149,772 | 149,772 | 149,772 |
| End Cash Position | 93,916 | 115,858 | 80,801 | 100,340 | 114,604 |
| Net Cash Flow | $13,115 | $35,057 | $-68,971 | $-49,432 | $-35,168 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,638 | -27,347 | -73,305 | -54,251 | -41,244 |
| Capital Expenditure | -575 | -391 | -2,280 | -2,130 | -1,637 |
| Free Cash Flow | -49,213 | -27,738 | -75,585 | -56,381 | -42,881 |